Analyst Targets 300% Upside for This Drug Stock

H.C. Wainwright also placed a "buy" rating on OTLK

Jul 18, 2019 at 9:30 AM
facebook X logo linkedin


H.C. Wainwright initiated coverage on Outlook Therapeutics Inc (NASDAQ:OTLK) with a "buy" rating and an $8 price target -- a 310% premium to last night's close. The brokerage firm said it expects the company to receive regulatory approval by 2022 for its drug candidate ONS-5010, which is currently being tested in late-stage trials to treat patients with wet age-related macular degeneration (wet AMD) and other retina diseases.

In reaction, OTLK stock is up 15.4% at $2.25, headed toward its best day since June 14, when it surged 20.8%. Nevertheless, the shares are still down 44% year-to-date, and have surrendered 69% since hitting an annual high of $10.96 on Feb. 14. Plus, Outlook Therapeutics has failed to fill a mid-April bear gap near $3 -- a level that quickly contained a late-May rally attempt.

Analysts are overwhelmingly upbeat toward the drug stock, though, with 100% in coverage maintaining a "buy" or better. Additionally, the average 12-month price target of $7.50 sits in territory not charted since early April.

Short sellers, on the other hand, have been actively betting against the stock. There are currently 1.4 million OTLK shares sold short, which represents a significant 20% of the equity's available float. This could be amplifying today's upside, as some of the weaker bearish hands rush to cover.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI